USE OF PROTEIN HYDROLYSATES FOR THE MANUFACTURE OF A MEDICAMENT FOR PROPHYLAXIS AND/OR TREATMENT OF A DPP-IV MEDIATED CONDITION

摘要

Disclosed is the use of one or more protein hydrolysates for the manufacture of a medicament, food supplement, beverage or food product for prophylaxis and/or treatment of a DDP-IV mediated condition, like for example obesity, type II diabetes mellitus, autoimmune diseases.